India Pharma Outlook (@pharma_outlook) 's Twitter Profile
India Pharma Outlook

@pharma_outlook

Pharma Outlook provides the industry experts analysis of the key pressures facing the Pharma Industry in the year ahead

ID: 1483670843402387456

linkhttps://www.indiapharmaoutlook.com/ calendar_today19-01-2022 05:22:08

1,1K Tweet

247 Followers

462 Following

India Pharma Outlook (@pharma_outlook) 's Twitter Profile Photo

Bristol Myers Squibb Reports Strong Phase 3 Results for Deucravacitinib trail News: qrcd.org/8rbM Bristol Myers Squibb #DeucravacitinibTrail #ActivePsoriaticArthritis #SkinImprovement #TherapeuticApproach

Bristol Myers Squibb Reports Strong Phase 3 Results for Deucravacitinib trail

News: qrcd.org/8rbM

<a href="/bmsnews/">Bristol Myers Squibb</a> 

#DeucravacitinibTrail #ActivePsoriaticArthritis #SkinImprovement #TherapeuticApproach
India Pharma Outlook (@pharma_outlook) 's Twitter Profile Photo

Eli Lilly Obesity Drug Shows 11.5% Weight Loss in 12 Weeks News: qrcd.org/8rs8 Novo Nordisk Eli Lilly and Company #WeightLossTherapies #PancreaticHormone #ObesityDrugTherapy #EarlyStageData

Eli Lilly Obesity Drug Shows 11.5% Weight Loss in 12 Weeks

News: qrcd.org/8rs8

<a href="/novonordisk/">Novo Nordisk</a> 
<a href="/EliLillyandCo/">Eli Lilly and Company</a> 

#WeightLossTherapies #PancreaticHormone #ObesityDrugTherapy #EarlyStageData
India Pharma Outlook (@pharma_outlook) 's Twitter Profile Photo

Lupin signs deal with China's SUP for Tiotropium DPI rollout News: qrcd.org/8sDj Lupin #SinoUniversalPharmaceuticals #RespiratoryIllness #RegulatoryApprovals #RespiratoryHealthSector

Lupin signs deal with China's SUP for Tiotropium DPI rollout

News: qrcd.org/8sDj

<a href="/LupinGlobal/">Lupin</a> 

#SinoUniversalPharmaceuticals #RespiratoryIllness #RegulatoryApprovals #RespiratoryHealthSector
India Pharma Outlook (@pharma_outlook) 's Twitter Profile Photo

J&J Reports Durable Response in EMD Myeloma With Dual Therapy News: qrcd.org/8sXV Johnson & Johnson #DualTherapy #ExtramedullaryDisease #MyelomaResistance #DualAntigenTargeting

J&amp;J Reports Durable Response in EMD Myeloma With Dual Therapy

News: qrcd.org/8sXV

<a href="/JNJNews/">Johnson & Johnson</a> 

#DualTherapy #ExtramedullaryDisease #MyelomaResistance #DualAntigenTargeting
India Pharma Outlook (@pharma_outlook) 's Twitter Profile Photo

Alembic Pharma Gets USFDA EIR for API Unit in Gujarat News: bit.ly/4kQUw82 Alembic Pharmaceuticals #PharmaceuticalProduction #GenericsProducts #USMarket #OperationalChallenges

Alembic Pharma Gets USFDA EIR for API Unit in Gujarat

News: bit.ly/4kQUw82

<a href="/Alembic_Pharma/">Alembic Pharmaceuticals</a> 

#PharmaceuticalProduction #GenericsProducts #USMarket #OperationalChallenges
India Pharma Outlook (@pharma_outlook) 's Twitter Profile Photo

Eli Lilly Plans Appeal Over UK Refusal to Fund Kisunla Drug News: lnkd.in/dgve7xvS Eli Lilly and Company #ClinicalExperts #CognitiveImpairment #MildDementia #lzheimerDisease

Eli Lilly Plans Appeal Over UK Refusal to Fund Kisunla Drug

News: lnkd.in/dgve7xvS

<a href="/EliLillyandCo/">Eli Lilly and Company</a> 

#ClinicalExperts #CognitiveImpairment #MildDementia #lzheimerDisease
India Pharma Outlook (@pharma_outlook) 's Twitter Profile Photo

Lilly's Oral Obesity Drug Shows Promise in Phase-III Diabetes Trial News: qrcd.org/8tSl Eli Lilly and Company #DiabetesTrial #LoweringBloodSugar #AmericanDiabetesAssociations #DrugOrforglipron

Lilly's Oral Obesity Drug Shows Promise in Phase-III Diabetes Trial

News: qrcd.org/8tSl

<a href="/EliLillyandCo/">Eli Lilly and Company</a> 

#DiabetesTrial #LoweringBloodSugar #AmericanDiabetesAssociations #DrugOrforglipron
India Pharma Outlook (@pharma_outlook) 's Twitter Profile Photo

Needle-free HIV vaccine study begins with Immuno Cure, PharmaJet News: bit.ly/44no3iO #HIVVaccine #ClinicalStudy #WalesHospital #AIDSInstitute

Needle-free HIV vaccine study begins with Immuno Cure, PharmaJet

News: bit.ly/44no3iO

#HIVVaccine #ClinicalStudy #WalesHospital #AIDSInstitute
India Pharma Outlook (@pharma_outlook) 's Twitter Profile Photo

India's 1st Gender-Neutral HPV Shot Powers Serum's Cervavac Campaign News: lnkd.in/ghSuw9-2 SerumInstituteIndia #HPVAssociatedCancers #CervicalCancer #MedicalExperts #PaediatricInfectiousDisease

India's 1st Gender-Neutral HPV Shot Powers Serum's Cervavac Campaign

News: lnkd.in/ghSuw9-2

<a href="/SerumInstIndia/">SerumInstituteIndia</a> 

#HPVAssociatedCancers #CervicalCancer #MedicalExperts
#PaediatricInfectiousDisease
India Pharma Outlook (@pharma_outlook) 's Twitter Profile Photo

Bharat Biotech and GSK Cut Malaria Vaccine Price to Save More Lives in Africa News: lnkd.in/gEjM6-Qn GSK Bharat Biotech #MalariaVaccinePrice #MultinationalPharmaceuticalCorporation #ProductionCapacity #AffordableManufacturing

Bharat Biotech and GSK Cut Malaria Vaccine Price to Save More Lives in Africa

News: lnkd.in/gEjM6-Qn

<a href="/GSK/">GSK</a> 
<a href="/BharatBiotech/">Bharat Biotech</a> 

#MalariaVaccinePrice #MultinationalPharmaceuticalCorporation
#ProductionCapacity #AffordableManufacturing
India Pharma Outlook (@pharma_outlook) 's Twitter Profile Photo

India to Curb Open Market Access to Key TB Drugs Amid Resistance Concerns News: lnkd.in/guCHewNG #TBDrugs #IndianGovernment #DrugsConsultativeCommittee #GenericVersions

India to Curb Open Market Access to Key TB Drugs Amid Resistance Concerns

News: lnkd.in/guCHewNG

#TBDrugs #IndianGovernment #DrugsConsultativeCommittee
#GenericVersions
India Pharma Outlook (@pharma_outlook) 's Twitter Profile Photo

Torrent Pharma Close to Finalising Stake Acquisition in JB Pharma Read More: lnkd.in/gbAgfVVQ #PrivateEquity #PublicShareholders #CentralNervousSystem #IndianBrandedBusiness #SkinCareProducts

Torrent Pharma Close to Finalising Stake Acquisition in JB Pharma

Read More: lnkd.in/gbAgfVVQ

#PrivateEquity #PublicShareholders #CentralNervousSystem
#IndianBrandedBusiness #SkinCareProducts